CA
CAPR icon

Cliff Asness’s Capricor Therapeutics CAPR Stock Holding History

Cliff Asness’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$215K Sell
8,948
-1,074
-11% -$32.6K ﹤0.01% 3783
2026
Q1 		$305K Buy
10,022
+1,426
+17% +$38K ﹤0.01% 3399
2025
Q4 		$248K Sell
8,596
-3,765
-30% -$49.2K ﹤0.01% 3259
2025
Q3 		$89.1K Buy
+12,361
New +$91K ﹤0.01% 3377
2025
Q1 		– Sell
-11,097
Closed -$153K – 3158
2024
Q4 		$153K Sell
11,097
-28,519
-72% -$500K ﹤0.01% 2713
2024
Q3 		$603K Buy
+39,616
New +$196K ﹤0.01% 2081

Other funds holding CAPR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Cliff Asness's CAPR Position: Q2 2026 in Review

Cliff Asness reduced its Capricor Therapeutics (CAPR) stake by 11% in Q2 2026, selling an estimated $32.6K and leaving 8,948 shares worth $215K. The position accounts for ﹤0.01% of the portfolio, ranked #3783.

Cliff Asness first reported a position in CAPR in Q3 2024 and has held it in 6 quarters since. The position peaked at $603K in Q3 2024. 169 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.

  • Cliff Asness held 8,948 shares of Capricor Therapeutics worth $215K as of Q2 2026.
  • Cliff Asness sold 1,074 Capricor Therapeutics shares in Q2 2026, an estimated $32.6K.
  • Capricor Therapeutics made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #3783 holding.
  • Cliff Asness first reported a position in Capricor Therapeutics in Q3 2024 and has held it in 6 quarters since.
  • Cliff Asness's Capricor Therapeutics position peaked at $603K in Q3 2024.
  • 169 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.